2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit

This Event has Passed

Tuesday, June 20, 2023 - 7:30 AM
to Thursday, June 22, 2023 - 5:00 PM

Add to Calendar

06/20/2023 07:30 AM 06/22/2023 05:00 PM America/Anguilla 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit With 9 preclinical candidates actively being studied and 21 clinical trials taking place, the Adenosine landscape is bubbling with activity! No stone is left unturned as CD73, CD39, A1AR, A2AR, and Interior adenosine pathways are exploited. The field is poised to leap on the momentum from clinical success at the 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit. Returning as the premier event devoted to improving the efficacy of drugs that target the adenosine pathway, overcoming obstacles related to resistance and immunosuppression, and accelerating the translation of therapeutics into the clinic. Join experts in adenosine, immune checkpoint, tumor microenvironment, immune-... Details & Tickets: https://www.upcomingevents.com/boston/events/boston-park-plaza/2nd-annual-adenosine-pathway-targeted-cancer-immunotherapy-summit-89758?ref=uceaddevent Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116

Neighborhoods

Back Bay (Boston)
Bay Village (Boston)
Beacon Hill (Boston)
Chinatown (Boston)

View Event Website »

With 9 preclinical candidates actively being studied and 21 clinical trials taking place, the Adenosine landscape is bubbling with activity! No stone is left unturned as CD73, CD39, A1AR, A2AR, and Interior adenosine pathways are exploited. The field is poised to leap on the momentum from clinical success at the 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit. Returning as the premier event devoted to improving the efficacy of drugs that target the adenosine pathway, overcoming obstacles related to resistance and immunosuppression, and accelerating the translation of therapeutics into the clinic. Join experts in adenosine, immune checkpoint, tumor microenvironment, immune-oncology, and second-generation IO as they learn how combination medicines might improve the effectiveness and potency of treatment. With more speakers, content, and networking opportunities than ever before, don't miss this opportunity to overcome these obstacles and exploit the adenosine pathway's therapeutic and commercial potential.

Event Links

Website: https://go.evvnt.com/1590511-0

Tickets: https://go.evvnt.com/1590511-2

Brochure: https://go.evvnt.com/1590511-3

View Less